Registered entities
Satsuma Pharmaceuticals, Inc.
Reg. No. 813039831United States
Innovation
3 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 424 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Social engagement
Social engagement: 1.8K social following, 1 post in the last 12 months — top quartile of its industry.
Investor mix
18 investors on record; lead investors include Wellington, TPG, RA Capital Management, SNBL; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 28% |
| Private equity | 3 | 17% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 9 | 50% |